A Randomized, Open Label, Active Controlled, Phase II/III Clinical Study to Assess the Safety and Immunogenicity of SIIL's Purified Vero Cell Rabies Vaccine (PVRV) in Patients with Potential Rabies Exposure

Trial Profile

A Randomized, Open Label, Active Controlled, Phase II/III Clinical Study to Assess the Safety and Immunogenicity of SIIL's Purified Vero Cell Rabies Vaccine (PVRV) in Patients with Potential Rabies Exposure

Completed
Phase of Trial: Phase II/III

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Rabies vaccine (Primary) ; Rabies vaccine (Primary) ; Rabies immune globulin
  • Indications Rabies
  • Focus Pharmacodynamics; Registrational
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 20 Aug 2016 Results published in the Vaccine
    • 21 Jan 2013 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
    • 15 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top